A Study of Bevacizumab (Avastin) in Women With HER2 Negative Metastatic Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: Docetaxel|DRUG: Placebo to bevacizumab|DRUG: Bevacizumab
Sponsor: Hoffmann-La Roche